Jaguar Health, Inc. SEC filings JAGX
Jaguar Health, Inc. has 1,004 filings in SEC EDGAR's recent list, going back to Jun 16, 2016. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 19, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3/A | Filing | Nov 3, 2026 | — |
| 8-K |
Current report
Other events
|
Nov 3, 2026 | Nov 2, 2026 |
| DEFA14A | Additional proxy material | Oct 29, 2026 | — |
| 8-K |
Current report
Other events
|
Oct 28, 2026 | Oct 27, 2026 |
| S-3 | Shelf registration | Oct 22, 2026 | — |
| DEF 14A | Proxy statement | Oct 8, 2026 | Nov 6, 2026 |
| 8-K |
Current report
Material agreement, New debt, Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure, Other events
|
Oct 5, 2026 | Sep 30, 2026 |
| PRER14A | Filing | Sep 29, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Sep 28, 2026 | Sep 25, 2026 |
| 8-K |
Current report
Material agreement, Agreement ended, Unregistered share sale, Other events
|
Sep 25, 2026 | Sep 23, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Sep 24, 2026 | — |
| 424B5 | Prospectus supplement | Sep 24, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Sep 24, 2026 | Sep 23, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Sep 21, 2026 | Sep 15, 2026 |
| PRE 14A | Preliminary proxy statement | Sep 18, 2026 | Oct 23, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Sep 15, 2026 | Sep 11, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Sep 15, 2026 | Sep 14, 2026 |
| 8-K |
Current report
Other events
|
Sep 4, 2026 | Sep 4, 2026 |
| 424B5 | Prospectus supplement | Sep 3, 2026 | — |
| 424B3 | Prospectus | Aug 21, 2026 | — |
| 8-K |
Current report
Results of operations
|
Aug 19, 2026 | Aug 19, 2026 |
| 10-Q | Quarterly report | Aug 19, 2026 | Jun 30, 2026 |
| EFFECT | Filing | Aug 14, 2026 | — |
| NT 10-Q | Filing | Aug 14, 2026 | Jun 30, 2026 |
| POS AM | Filing | Aug 11, 2026 | — |
| DEF 14A | Proxy statement | Aug 3, 2026 | Sep 4, 2026 |
| 424B3 | Prospectus | Jul 27, 2026 | — |
| 424B3 | Prospectus | Jul 27, 2026 | — |
| EFFECT | Filing | Jul 24, 2026 | — |
| EFFECT | Filing | Jul 24, 2026 | — |
| PRE 14A | Preliminary proxy statement | Jul 24, 2026 | Sep 4, 2026 |
| S-1/A | Amended registration statement | Jul 24, 2026 | — |
| S-1 | Registration statement | Jul 16, 2026 | — |
| S-1 | Registration statement | Jul 16, 2026 | — |
| 8-K |
Current report
Material agreement
|
Jul 14, 2026 | Jul 9, 2026 |
| 8-K |
Current report
Other events
|
Jul 1, 2026 | Jul 1, 2026 |
| D | Filing | Jul 1, 2026 | — |
| D | Filing | Jul 1, 2026 | — |
| 8-K |
Current report
Material agreement, Other events
|
Jun 25, 2026 | Jun 22, 2026 |
| 8-K/A |
Amended current report
Regulation FD disclosure
|
Jun 22, 2026 | Jun 22, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 22, 2026 | Jun 22, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jun 18, 2026 | Jun 17, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change
|
Jun 11, 2026 | Jun 8, 2026 |
| 8-K |
Current report
Shareholder vote results, Regulation FD disclosure
|
Jun 8, 2026 | Jun 8, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jun 2, 2026 | Jun 1, 2026 |
| DEFA14A | Additional proxy material | May 29, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 27, 2026 | May 26, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
May 22, 2026 | May 21, 2026 |
| 8-K |
Current report
Results of operations
|
May 20, 2026 | May 20, 2026 |
| 10-Q | Quarterly report | May 20, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Bylaw or fiscal year change
|
May 19, 2026 | May 19, 2026 |
| NT 10-Q | Filing | May 18, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Other events
|
May 7, 2026 | May 6, 2026 |
| DEFA14A | Additional proxy material | May 6, 2026 | — |
| 8-K |
Current report
Other events
|
May 4, 2026 | May 4, 2026 |
| 8-K |
Current report
Listing notice
|
May 4, 2026 | May 1, 2026 |
| DEF 14A | Proxy statement | Apr 30, 2026 | May 22, 2026 |
| ARS | Annual report to shareholders | Apr 30, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Listing notice, Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Apr 27, 2026 | Apr 24, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results, Regulation FD disclosure
|
Apr 21, 2026 | Apr 20, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 20, 2026 | May 22, 2026 |
| 8-K |
Current report
Other events
|
Apr 9, 2026 | Apr 7, 2026 |
| S-8 | Employee stock plan registration | Apr 7, 2026 | — |
| 8-K |
Current report
Results of operations
|
Apr 7, 2026 | Apr 7, 2026 |
| 10-K | Annual report | Apr 7, 2026 | Dec 31, 2025 |
| NT 10-K | Filing | Apr 1, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | Mar 24, 2026 | Apr 20, 2026 |
| PRE 14A | Preliminary proxy statement | Mar 13, 2026 | Apr 20, 2026 |
| 4 | Insider transaction | Mar 12, 2026 | Dec 11, 2025 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt
|
Mar 9, 2026 | Mar 6, 2026 |
| 8-K |
Current report
Listing notice
|
Mar 6, 2026 | Mar 5, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Mar 3, 2026 | Mar 2, 2026 |
| 8-K |
Current report
Change to shareholder rights, Regulation FD disclosure, Other events
|
Feb 18, 2026 | Feb 18, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 10, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jan 23, 2026 | Jan 16, 2026 |
| 4 | Insider transaction | Jan 21, 2026 | Dec 11, 2025 |
| 4 | Insider transaction | Jan 21, 2026 | Dec 11, 2025 |
| 4 | Insider transaction | Jan 21, 2026 | Dec 11, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jan 15, 2026 | Jan 12, 2026 |
| 8-K/A |
Amended current report
Material agreement, New debt, Unregistered share sale
|
Jan 12, 2026 | Jan 6, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jan 12, 2026 | Jan 12, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jan 12, 2026 | Jan 5, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 5, 2026 | — |
| 4 | Insider transaction | Dec 15, 2025 | Dec 11, 2025 |
| 4 | Insider transaction | Dec 15, 2025 | Dec 11, 2025 |
| 4 | Insider transaction | Dec 15, 2025 | Dec 11, 2025 |
| 4 | Insider transaction | Dec 15, 2025 | Dec 11, 2025 |
| 4 | Insider transaction | Dec 15, 2025 | Dec 11, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Dec 12, 2025 | Dec 12, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Dec 11, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Dec 11, 2025 | — |
| 8-K |
Current report
Shareholder vote results, Regulation FD disclosure
|
Dec 8, 2025 | Dec 8, 2025 |
| EFFECT | Filing | Nov 25, 2025 | — |
| 424B3 | Prospectus | Nov 25, 2025 | — |
| D | Filing | Nov 24, 2025 | — |
| CORRESP | Letter to the SEC | Nov 24, 2025 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Nov 19, 2025 | Nov 17, 2025 |
| 8-K |
Current report
Material agreement, New debt
|
Nov 14, 2025 | Nov 14, 2025 |
| 10-Q | Quarterly report | Nov 14, 2025 | Sep 30, 2025 |
| DEF 14A | Proxy statement | Nov 10, 2025 | Dec 8, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 7, 2025 | — |
| PRE 14A | Preliminary proxy statement | Oct 28, 2025 | Dec 8, 2025 |
| D | Filing | Oct 10, 2025 | — |
| 8-K |
Current report
Unregistered share sale
|
Oct 3, 2025 | Sep 30, 2025 |
| S-3 | Shelf registration | Oct 3, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Oct 1, 2025 | Sep 28, 2025 |
| D | Filing | Sep 23, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change
|
Sep 11, 2025 | Sep 9, 2025 |
| 3 | Initial insider ownership | Aug 29, 2025 | Aug 28, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 29, 2025 | — |
| 8-K |
Current report
Shareholder vote results, Regulation FD disclosure
|
Aug 19, 2025 | Aug 19, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| 8-K |
Current report
Material agreement
|
Aug 14, 2025 | Aug 14, 2025 |
| 424B5 | Prospectus supplement | Aug 14, 2025 | — |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| DEFA14A | Additional proxy material | Aug 6, 2025 | — |
| EFFECT | Filing | Jul 30, 2025 | — |
| 424B3 | Prospectus | Jul 30, 2025 | — |
| CORRESP | Letter to the SEC | Jul 28, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 28, 2025 | — |
| S-3 | Shelf registration | Jul 24, 2025 | — |
| ARS | Annual report to shareholders | Jul 21, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Jul 21, 2025 | Aug 19, 2025 |
| PRE 14A | Preliminary proxy statement | Jul 11, 2025 | Aug 19, 2025 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Bylaw or fiscal year change
|
Jun 30, 2025 | Jun 27, 2025 |
| EFFECT | Filing | Jun 27, 2025 | — |
| 424B3 | Prospectus | Jun 27, 2025 | — |
| 424B5 | Prospectus supplement | Jun 27, 2025 | — |
| 4 | Insider transaction | Jun 26, 2025 | Jun 24, 2025 |
| 4 | Insider transaction | Jun 26, 2025 | Jun 24, 2025 |
| 4 | Insider transaction | Jun 26, 2025 | Jun 24, 2025 |
| 4 | Insider transaction | Jun 26, 2025 | Jun 24, 2025 |
| 4 | Insider transaction | Jun 26, 2025 | Jun 24, 2025 |
| 4 | Insider transaction | Jun 26, 2025 | Jun 24, 2025 |
| 4 | Insider transaction | Jun 26, 2025 | Jun 24, 2025 |
| CORRESP | Letter to the SEC | Jun 25, 2025 | — |
| UPLOAD | Letter from the SEC | Jun 25, 2025 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Other events
|
Jun 24, 2025 | Jun 24, 2025 |
| S-3 | Shelf registration | Jun 20, 2025 | — |
| D | Filing | May 28, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 28, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 28, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 27, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
May 22, 2025 | May 20, 2025 |
| 424B5 | Prospectus supplement | May 22, 2025 | — |
| 424B5 | Prospectus supplement | May 21, 2025 | — |
| 4 | Insider transaction | May 20, 2025 | May 17, 2025 |
| 4 | Insider transaction | May 20, 2025 | May 17, 2025 |
| 8-K |
Current report
Material agreement, Results of operations, New debt, Unregistered share sale, Bylaw or fiscal year change
|
May 15, 2025 | May 13, 2025 |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
May 9, 2025 | May 9, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 8, 2025 | — |
| EFFECT | Filing | May 7, 2025 | — |
| 424B3 | Prospectus | May 7, 2025 | — |
| CORRESP | Letter to the SEC | May 5, 2025 | — |
| 424B5 | Prospectus supplement | May 5, 2025 | — |
| 8-K |
Current report
Material agreement
|
May 5, 2025 | May 5, 2025 |
| 8-K |
Current report
Unregistered share sale
|
May 2, 2025 | Apr 30, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 30, 2025 | Apr 30, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 28, 2025 | Apr 28, 2025 |
| S-3/A | Filing | Apr 25, 2025 | — |
| CORRESP | Letter to the SEC | Apr 25, 2025 | — |
| 8-K/A |
Amended current report
Material agreement, New debt, Unregistered share sale
|
Apr 25, 2025 | Jan 29, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 25, 2025 | Apr 25, 2025 |
| UPLOAD | Letter from the SEC | Apr 24, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 21, 2025 | Apr 18, 2025 |
| S-8 | Employee stock plan registration | Apr 15, 2025 | — |
| S-3 | Shelf registration | Apr 15, 2025 | — |
| 10-K/A | Amended annual report | Apr 15, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 4, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2025 | Mar 31, 2025 |
| 10-K | Annual report | Mar 31, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Other events
|
Mar 26, 2025 | Mar 26, 2025 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Mar 18, 2025 | Mar 18, 2025 |
| 8-K |
Current report
Shareholder vote results, Regulation FD disclosure
|
Mar 13, 2025 | Mar 13, 2025 |
| 8-A12B | Filing | Feb 27, 2025 | — |
| 8-K |
Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Feb 27, 2025 | Feb 26, 2025 |
| DEF 14A | Proxy statement | Feb 24, 2025 | Mar 13, 2025 |
| 8-K |
Current report
Material agreement, Auditor change
|
Feb 20, 2025 | Feb 19, 2025 |
| PRE 14A | Preliminary proxy statement | Feb 14, 2025 | Mar 13, 2025 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Feb 4, 2025 | Jan 28, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 29, 2025 | — |
| 8-K |
Current report
Material agreement
|
Nov 13, 2024 | Nov 13, 2024 |
| 424B5 | Prospectus supplement | Nov 13, 2024 | — |
| 8-K |
Current report
Results of operations
|
Nov 13, 2024 | Nov 13, 2024 |
| 10-Q | Quarterly report | Nov 13, 2024 | Sep 30, 2024 |
| 4 | Insider transaction | Oct 10, 2024 | Oct 8, 2024 |
| 4 | Insider transaction | Oct 10, 2024 | Oct 8, 2024 |
| 4 | Insider transaction | Oct 10, 2024 | Oct 8, 2024 |
| 4 | Insider transaction | Oct 10, 2024 | Oct 8, 2024 |
| 4 | Insider transaction | Oct 10, 2024 | Oct 8, 2024 |
| 4 | Insider transaction | Oct 10, 2024 | Oct 8, 2024 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- JAGX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Francisco, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1585608
- Former names
- Jaguar Animal Health, Inc. (until Jul 31, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.